REGN

Regeneron Pharmaceuticals, Inc.

NMS · Healthcare

$746.54

$6.97 (+0.94%)up 0.94%

12 October 2026 · delayed 15+ min

D+

Quality score68.8 / 100

Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.

Regeneron Pharmaceuticals, Inc. earns a D+ on excellent profit margins (>20%) and strong current ratio (>2.0) but high debt-to-equity ratio (>2.0) and negative earnings growth. Reasonable investment with moderate upside potential.

Model stance HOLD Suggested position 5.1% · $510.00 IQInvest estimate
Adjusted for Moderate investors, Medium-term investors 5.1% suggested allocation Change these

These change the suggested position size and the stance, not the category scores. Amount is in dollars.

IQ-REGN-20261012engine v1 · 7-category weighted scorecard

What it is worth, depending who you ask.

Today’s price against the year it has had and the targets analysts publish. Every marker is a reported figure, not a projection of ours.

52-week low

$541.00

Lowest analyst target

$730.00

Today's price

$746.54

Mean analyst target

$859.04

52-week high

$859.34

Highest analyst target

$1,030.00

REGN trades 65% of the way up its 52-week range, between $541.00 and $859.34. The mean analyst target of $859.04 is 15.1% above today's price.

Today’s price 52-week range Analyst price targets

Scored categories

Financial healthExcellent profit margins (>20%); Strong current ratio (>2.0); High debt-to-equity ratio (>2.0); Negative earnings growth 85.023%

Profit margin

27.87%

Net profit per unit of revenue

exceptionalWhat this means

Of every 100 units of revenue, this much survives as profit.

Margins this wide usually mean real pricing power or a moat.

Operating margin

33.11%

Before interest and tax

very highWhat this means

Profit from operations, before interest and tax, per 100 of revenue.

Typical of software and other businesses with little cost per extra sale.

Gross margin

44.46%

After the cost of goods only

moderateWhat this means

What is left of revenue after only the direct cost of the product.

A conventional manufacturing or mixed-model range.

Return on equity

14.04%

Profit per unit of shareholder capital

strongWhat this means

Profit generated per unit of shareholder capital.

Above 15% is generally considered a good business.

Return on assets

6.53%

Profit per unit of assets

strongWhat this means

Profit generated per unit of everything the company owns.

The assets are working hard.

Debt to equity

8.54

Borrowings against equity

conservativeWhat this means

Borrowings measured against shareholder capital.

Comfortably financed.

Current ratio

3.33

Short-term assets over short-term debts

very liquidWhat this means

Short-term assets against short-term obligations.

Plenty of cover, though idle cash earns little.

Quick ratio

2.63

As above, excluding inventory

comfortableWhat this means

Short-term assets excluding inventory, against short-term debts.

Liquid assets exceed short-term obligations.

Revenue growth

16.70%

Year on year

growingWhat this means

Change in revenue against the same period last year.

A healthy expansion rate.

Earnings growth

-4.50%

Year on year

fallingWhat this means

Change in earnings against the same period last year.

Profit is declining even if revenue is not.

Revenue

$7.90B

Trailing twelve months

Free cash flow

$3.07B

Cash left after capital spending

Operating cash flow

$4.68B

Cash from the business itself

Payout ratio

9.00%

Dividends as a share of earnings

conservativeWhat this means

The share of earnings paid out as dividends.

Comfortably covered, with room to keep raising it.

Growth & momentumStrong 1-year return (31.7%); Low Sharpe ratio (0.30); Severe max drawdown (-59.7%) 55.022%

Return, 1 month

-4.47%

Return, 3 months

13.91%

Return, 6 months

0.28%

Return, year to date

-3.46%

Return, 1 year

31.67%

Return, 3 years

-9.33%

Sharpe ratio

0.30

Return earned per unit of risk

modestWhat this means

Return earned per unit of risk taken.

Below 1 is the common case; return did not strongly outpace the volatility.

Win rate

51.12%

Share of days that closed up

about evenWhat this means

The share of trading days that closed higher.

Close to a coin flip, which is the norm — returns come from the size of moves, not their count.

Average daily return

0.04%

Best day

18.85%

Worst day

-19.01%

Valuation9 measured figures 80.018%

P/E ratio

18.46

Price against trailing earnings

moderateWhat this means

You pay 18.46 for every 1 unit of annual earnings.

Roughly the long-run market average band.

Forward P/E

12.11

Price against forecast earnings

lowWhat this means

Price against next year's *forecast* earnings.

The market expects little growth, or doubts the forecast.

PEG ratio

1.27

P/E adjusted for growth

fairWhat this means

P/E divided by the growth rate — it asks whether the price is justified by the growth.

Between 1 and 2 price and growth are roughly in step.

Price to book

2.36

Price against balance-sheet equity

normalWhat this means

Price against the accounting value of the company's net assets.

A typical range for an established company.

Price to sales

4.95

Price against revenue

highWhat this means

Price against revenue — usable when a company has no profit yet.

The price assumes today's revenue will convert into much more profit later.

EV / EBITDA

14.73

Whole-company value against cash earnings

moderateWhat this means

Whole-company value, debt included, against cash earnings.

A conventional range.

Enterprise value

$69.26B

Market value plus debt, minus cash — the price of the whole business

Shares outstanding

101,137,842

Shares the profit is split across

Dividend yield

0.50%

Annual dividend against price

modestWhat this means

Annual dividend as a percentage of the share price.

A small income component.

TechnicalRSI in healthy range (30-70); MACD bearish (negative histogram) 60.015%

RSI (14)

42.1

Above 70 overbought, below 30 oversold

neutralWhat this means

A 0–100 momentum gauge over the last 14 sessions.

The middle band, where most trading days sit.

MACD

-14.26

Momentum against its own trend

MACD histogram

-3.35

Positive is bullish

ADX

19.6

Trend strength; above 25 is a real trend

no clear trendWhat this means

Trend strength, regardless of direction.

Below about 20 the price is ranging rather than trending.

20-day average

$766.46

50-day average

$789.47

200-day average

$734.12

Price vs 50-day

-5.44%

Price vs 200-day

1.69%

Bollinger upper

$818.07

Bollinger lower

$714.85

Average true range

20.41

Typical daily trading range

Stochastic %K

26.8

RiskHigh drawdown risk 40.012%

Volatility, annualised

31.08%

How far it swings in a year

normalWhat this means

How far the price typically swings over a year.

A typical range for an individual share.

Beta

0.15

Moves against the wider market

steadier than the marketWhat this means

How much the price moves relative to the wider market.

Tends to move less than the index, in both directions.

Maximum drawdown

-59.69%

Worst peak-to-trough fall

severeWhat this means

The worst peak-to-trough fall in the period measured.

A fall this deep needs roughly a doubling to recover.

Risk category

High

The engine's own banding

Analyst viewAnalyst consensus: Buy; Strong analyst coverage (26 analysts) 90.010%

Consensus

Buy

What covering analysts rate it

Analysts covering

26

Mean price target

$859.04

Highest target

$1,030.00

Lowest target

$730.00

Implied upside

15.07%

Target against today's price

meaningfulWhat this means

How far the mean analyst target sits above today's price.

Analysts see real room above today's price.

Price against the S&P 500

180 trading days to 2026-10-09

REGN is 0.5% down over the window, against 13.0% up for the S&P 500 — behind by 13.5 points.
REGN -0.5%S&P 500 +13.0%
Show the numbers
Sampled across the window. Both columns are rebased to 100 on 2026-01-23, so they can be compared directly.
DateCloseREGN rebasedS&P 500 rebased
2026-01-23$750.65100.0100.0
2026-02-13$800.07106.698.9
2026-03-09$779.52103.898.3
2026-03-30$747.3099.691.7
2026-04-21$745.3899.3102.1
2026-05-12$721.4996.1107.0
2026-06-03$618.2382.4109.2
2026-06-25$619.4282.5106.4
2026-07-17$675.9090.0107.8
2026-08-07$783.45104.4112.2
2026-08-28$794.19105.8111.5
2026-09-21$798.17106.3112.3

How the score was built

Each category is scored 0–100, then multiplied by its weight. The seven contributions sum to the quality score.
CategoryScoreWeightContribution
Financial health85.023%19.6
Growth & momentum55.022%12.1
Valuation80.018%14.4
Technical60.015%9.0
Risk40.012%4.8
Analyst view90.010%9.0
ESG50.00%0.0
Quality score100%68.8

ESG is scored but carries no weight in this grade. Add ?esg=1 to the address to include it — the engine then redistributes weight across the other six, so the whole scorecard changes, not just one row.

Argue with the model

Every other grader hands you a number. This one hands you the model.

Move a slider, press Recalculate, and the grade is rebuilt from the same category scores. Nothing is hidden: the scores are the engine's, only the weighting is yours.

What each model believes. Pick one above, or set your own sliders below.
ModelThe emphasis
IQInvest defaultThe engine's own weighting: financial health 23% and performance 22% lead, valuation 18%, then technicals, risk and analysts.
Value investorPrice against worth dominates: valuation 40%, financial health 25%. Chart signals count for almost nothing.
Growth investorMomentum first: performance 40% and technicals 20%. Whether the price is fair today gets just 5%.
Sleep at nightStability over everything: risk 35% and financial health 30% together outweigh all other categories combined.
ChartistThe tape over the fundamentals: technicals 45% and performance 25%. Valuation is nearly ignored.
18%
23%
22%
12%
15%
10%
0%

These are IQInvest's own weights, totalling 100%.

Your grade

D+

68.8 / 100

Identical to the IQInvest grade.

All 66 metricsOne flat sortable table, for when you want everything at once.
Metric Category Value Source
Shares outstandingValuation101,137,842Yahoo Finance
Price to salesValuation4.95Yahoo Finance
Price to bookValuation2.36Yahoo Finance
PEG ratioValuation1.27Yahoo Finance
P/E ratioValuation18.46Yahoo Finance
Forward P/EValuation12.11Yahoo Finance
EV / EBITDAValuation14.73Yahoo Finance
Enterprise valueValuation$69.26BYahoo Finance
Dividend yieldValuation0.50%Yahoo Finance
Stochastic %KTechnical26.8Yahoo Finance
RSI (14)Technical42.1Yahoo Finance
Price vs 50-dayTechnical-5.44%Yahoo Finance
Price vs 200-dayTechnical1.69%Yahoo Finance
MACD histogramTechnical-3.35Yahoo Finance
MACDTechnical-14.26Yahoo Finance
Bollinger upperTechnical$818.07Yahoo Finance
Bollinger lowerTechnical$714.85Yahoo Finance
Average true rangeTechnical20.41Yahoo Finance
ADXTechnical19.6Yahoo Finance
50-day averageTechnical$789.47Yahoo Finance
200-day averageTechnical$734.12Yahoo Finance
20-day averageTechnical$766.46Yahoo Finance
Volatility, annualisedRisk31.08%Yahoo Finance
Risk categoryRiskHighYahoo Finance
Maximum drawdownRisk-59.69%Yahoo Finance
BetaRisk0.15Yahoo Finance
VolumeMarket data466,026Yahoo Finance
Previous closeMarket data$739.57Yahoo Finance
OpenMarket data$737.20Yahoo Finance
EmployeesMarket data15,410Yahoo Finance
Day lowMarket data$733.70Yahoo Finance
Day highMarket data$751.27Yahoo Finance
Average volumeMarket data735,168Yahoo Finance
52-week lowMarket data$541.00Yahoo Finance
52-week highMarket data$859.34Yahoo Finance
Worst dayGrowth & momentum-19.01%Yahoo Finance
Win rateGrowth & momentum51.12%Yahoo Finance
Sharpe ratioGrowth & momentum0.30Yahoo Finance
Return, year to dateGrowth & momentum-3.46%Yahoo Finance
Return, 6 monthsGrowth & momentum0.28%Yahoo Finance
Return, 3 yearsGrowth & momentum-9.33%Yahoo Finance
Return, 3 monthsGrowth & momentum13.91%Yahoo Finance
Return, 1 yearGrowth & momentum31.67%Yahoo Finance
Return, 1 monthGrowth & momentum-4.47%Yahoo Finance
Best dayGrowth & momentum18.85%Yahoo Finance
Average daily returnGrowth & momentum0.04%Yahoo Finance
Revenue growthFinancial health16.70%Yahoo Finance
RevenueFinancial health$7.90BYahoo Finance
Return on equityFinancial health14.04%Yahoo Finance
Return on assetsFinancial health6.53%Yahoo Finance
Quick ratioFinancial health2.63Yahoo Finance
Profit marginFinancial health27.87%Yahoo Finance
Payout ratioFinancial health9.00%Yahoo Finance
Operating marginFinancial health33.11%Yahoo Finance
Operating cash flowFinancial health$4.68BYahoo Finance
Gross marginFinancial health44.46%Yahoo Finance
Free cash flowFinancial health$3.07BYahoo Finance
Earnings growthFinancial health-4.50%Yahoo Finance
Debt to equityFinancial health8.54Yahoo Finance
Current ratioFinancial health3.33Yahoo Finance
Mean price targetAnalyst view$859.04Yahoo Finance
Lowest targetAnalyst view$730.00Yahoo Finance
Implied upsideAnalyst view15.07%Yahoo Finance
Highest targetAnalyst view$1,030.00Yahoo Finance
ConsensusAnalyst viewBuyYahoo Finance
Analysts coveringAnalyst view26Yahoo Finance
Add to portfolio Compare Peers Set a price target

Yahoo Finance via yfinance · delayed 15 minutes or more